Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanoma

• Alpaslan Tasdogan, MD, PhD,
• Dirk Schadendorf, MD,
• Selma Ugurel, MD

Affiliations

Alpaslan Tasdogan, MD, PhD

Correspondence to: Alpaslan Tasdogan, MD, PhD, and Selma Ugurel, MD, Department of Dermatology, University Hospital Essen, Hufelandstr. 55, Essen, 45147, Germany.; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Essen, Germany

Dirk Schadendorf, MD

Department of Dermatology, University Hospital Essen, University Duisburg-Essen, German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Essen, Germany

Selma Ugurel, MD

Correspondence to: Alpaslan Tasdogan, MD, PhD, and Selma Ugurel, MD, Department of Dermatology, University Hospital Essen, Hufelandstr. 55, Essen, 45147, Germany.; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Essen, Germany